ENDRA Life Sciences Regains Nasdaq Compliance, Avoids Immediate Delisting
NDRA sits 60% above its 52-week low of $2.96.
Summary
Nasdaq has confirmed that ENDRA Life Sciences regained compliance with the minimum stockholders' equity rule, removing the immediate delisting threat. A one-year monitoring period now applies, during which any new deficiency would trigger immediate delisting.
Key Events · Legal and Risk Events · NDRA
-
Nasdaq Compliance Regained
On July 8, 2026, Nasdaq confirmed that ENDRA has regained compliance with the $2.5M minimum stockholders' equity requirement, resolving the delisting notice issued in April.
-
One-Year Monitoring Period Imposed
A Discretionary Panel Monitor will remain in place until July 1, 2027. Any new listing rule violation during this period will result in immediate delisting with no opportunity for a compliance plan.
-
Delisting Risk Not Eliminated
While the immediate threat is removed, the monitoring period means ENDRA remains at high risk of delisting if its financial condition deteriorates or if it fails to meet any other Nasdaq requirement.
-
Merger Context
Regaining compliance is crucial for the pending merger with Noble Africa, announced in late June and expected to transform the company. Maintaining the Nasdaq listing is likely a condition for the deal's completion.
Analysis · NDRA · Industrial Applications And Services
Since April, the stock has been overshadowed by an immediate delisting threat—one that has now been resolved. Nasdaq confirmed that the company meets the minimum stockholders' equity requirement, a critical milestone for a firm that was on the brink of being kicked off the exchange. The victory, however, comes with a one-year 'Discretionary Panel Monitor,' essentially a probation period. Should ENDRA trip any Nasdaq rule during that time, it faces immediate delisting with no grace period. This is a lifeline, not a clean bill of health, and the company remains under intense scrutiny as it works to close its pending merger with Noble Africa.
At the time of this filing, NDRA was trading at $4.73 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6M. The 52-week trading range was $2.96 to $11.96. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.